Topic
glaxosmithkline
1 market across Kalshi and Polymarket, $703 traded today.
| Market | Chance | 24h | Last 24h | Best price | Volume 24h |
|---|---|---|---|---|---|
 FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)EconomicsEnds Dec 31, 2026 | 89% | — |  92¢ | $703 |
Topic
1 market across Kalshi and Polymarket, $703 traded today.
| Market | Chance | 24h | Last 24h | Best price | Volume 24h |
|---|---|---|---|---|---|
| FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)EconomicsEnds Dec 31, 2026 | 89% | — | 92¢ | $703 |